HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The ISMRM Open Science Initiative for Perfusion Imaging (OSIPI): Results from the OSIPI-Dynamic Contrast-Enhanced challenge.

AbstractPURPOSE:
K trans $$ {K}^{\mathrm{trans}} $$ has often been proposed as a quantitative imaging biomarker for diagnosis, prognosis, and treatment response assessment for various tumors. None of the many software tools for K trans $$ {K}^{\mathrm{trans}} $$ quantification are standardized. The ISMRM Open Science Initiative for Perfusion Imaging-Dynamic Contrast-Enhanced (OSIPI-DCE) challenge was designed to benchmark methods to better help the efforts to standardize K trans $$ {K}^{\mathrm{trans}} $$ measurement.
METHODS:
A framework was created to evaluate K trans $$ {K}^{\mathrm{trans}} $$ values produced by DCE-MRI analysis pipelines to enable benchmarking. The perfusion MRI community was invited to apply their pipelines for K trans $$ {K}^{\mathrm{trans}} $$ quantification in glioblastoma from clinical and synthetic patients. Submissions were required to include the entrants' K trans $$ {K}^{\mathrm{trans}} $$ values, the applied software, and a standard operating procedure. These were evaluated using the proposed OSIP I gold $$ \mathrm{OSIP}{\mathrm{I}}_{\mathrm{gold}} $$ score defined with accuracy, repeatability, and reproducibility components.
RESULTS:
Across the 10 received submissions, the OSIP I gold $$ \mathrm{OSIP}{\mathrm{I}}_{\mathrm{gold}} $$ score ranged from 28% to 78% with a 59% median. The accuracy, repeatability, and reproducibility scores ranged from 0.54 to 0.92, 0.64 to 0.86, and 0.65 to 1.00, respectively (0-1 = lowest-highest). Manual arterial input function selection markedly affected the reproducibility and showed greater variability in K trans $$ {K}^{\mathrm{trans}} $$ analysis than automated methods. Furthermore, provision of a detailed standard operating procedure was critical for higher reproducibility.
CONCLUSIONS:
This study reports results from the OSIPI-DCE challenge and highlights the high inter-software variability within K trans $$ {K}^{\mathrm{trans}} $$ estimation, providing a framework for ongoing benchmarking against the scores presented. Through this challenge, the participating teams were ranked based on the performance of their software tools in the particular setting of this challenge. In a real-world clinical setting, many of these tools may perform differently with different benchmarking methodology.
AuthorsEve S Shalom, Harrison Kim, Rianne A van der Heijden, Zaki Ahmed, Reyna Patel, David A Hormuth 2nd, Julie C DiCarlo, Thomas E Yankeelov, Nicholas J Sisco, Richard D Dortch, Ashley M Stokes, Marianna Inglese, Matthew Grech-Sollars, Nicola Toschi, Prativa Sahoo, Anup Singh, Sanjay K Verma, Divya K Rathore, Anum S Kazerouni, Savannah C Partridge, Eve LoCastro, Ramesh Paudyal, Ivan A Wolansky, Amita Shukla-Dave, Pepijn Schouten, Oliver J Gurney-Champion, Radovan Jiřík, Ondřej Macíček, Michal Bartoš, Jiří Vitouš, Ayesha Bharadwaj Das, S Gene Kim, Louisa Bokacheva, Artem Mikheev, Henry Rusinek, Michael Berks, Penny L Hubbard Cristinacce, Ross A Little, Susan Cheung, James P B O'Connor, Geoff J M Parker, Brendan Moloney, Peter S LaViolette, Samuel Bobholz, Savannah Duenweg, John Virostko, Hendrik O Laue, Kyunghyun Sung, Ali Nabavizadeh, Hamidreza Saligheh Rad, Leland S Hu, Steven Sourbron, Laura C Bell, Anahita Fathi Kazerooni
JournalMagnetic resonance in medicine (Magn Reson Med) Vol. 91 Issue 5 Pg. 1803-1821 (May 2024) ISSN: 1522-2594 [Electronic] United States
PMID38115695 (Publication Type: Journal Article)
Copyright© 2023 International Society for Magnetic Resonance in Medicine.
Chemical References
  • Contrast Media
Topics
  • Humans
  • Contrast Media
  • Reproducibility of Results
  • Magnetic Resonance Imaging (methods)
  • Software
  • Algorithms

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: